Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_provenance.
- NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_assertion description "[Relevant to its clinical application, muMAb 4D5 may enhance the sensitivity of p185HER2-overexpressing tumor cells to cisplatin, a chemotherapeutic drug often used in the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_provenance.
- NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_assertion evidence source_evidence_literature NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_provenance.
- NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_assertion SIO_000772 1679763 NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_provenance.
- NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_assertion wasDerivedFrom befree-20140225 NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_provenance.
- NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_assertion wasGeneratedBy ECO_0000203 NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP184588.RAd2sF9Rd-m5I5dtRuLw6baaWxWkgzbaFM_gZ0Shax2PI130_provenance.